/Investor DB

InFocus Capital Partners, LLC — Full Portfolio

6 tracked investments · listed companies and verified rows first

ONL Therapeuticsonltherapeutics.comin✓ verified

ONL Therapeutics is a clinical-stage biopharmaceutical company developing therapies to preserve sight by preventing Fas-mediated death of retinal cells, a cause of vision loss and blindness.

BiotechHealthtechMedical DevicesAnn Arbor, US

David Zacks(Co-Founder & Chief Scientific Officer)inDavid Esposito(Executive Officer, Director)inConstance Chang(Executive Officer)John K Freshley(Executive Officer, Director)inJeffrey A Jamison(Executive Officer)in

BoardAaron Fletcher(Director)in

Co-investorsExSight VenturesInvest MichiganNovartis Venture FundVisionary VenturesBios PartnersJohnson & Johnson Innovation – JJDC+3 more

Trefoil Therapeuticstrefoiltherapeutics.comin✓ verified

Trefoil Therapeutics is a clinical-stage biotechnology company developing therapeutic agents for corneal diseases.

BiotechHealthtechMedical DevicesSan Diego, US

David Eveleth(Executive Officer, Director)inSchalon Newton(Executive Officer)in

BoardChristy Shaffer(Director)inRalph Bradshaw(Director)

Co-investorsExSight VenturesHatteras Venture PartnersSolasta VenturesAccess BiotechnologyBios PartnersCorrelation Ventures+1 more

2C Tech2ctechcorp.comDec 2019

HealthtechIrvine, US

JAMES TAYLOR(Executive Officer)IRVING ROBERT ARMSTRONG(Executive Officer)ROBERT SHIMIZU(Executive Officer)NARESH MANDAVA(Director)

BoardAKITERU FURUKAWA(Director)CLAUDE BENEDICT(Director)

Co-investorsExSight Ventures

Camras Visioncamrasvision.com𝕏Apr 2018 · $5.7M

Based in Research Triangle Park, NC

BiotechResearch Triangle Park, US

Lucinda Camras(Executive Officer, Director, Promoter)inRoberto Alfaro(Executive Officer, Director)Ray Krauss(Executive Officer, Director)

BoardRobert Rothman(Director)

Co-investorsCharlotte Angel FundHatteras Venture PartnersVCapital

Vanavana.org𝕏Nov 2022 · $11.9M

Vana is an open data infrastructure platform that enables individuals to control and manage the data they generate, with the ability to choose how it is used by AI systems.

AI & Machine LearningData & Infrastructure

Art Abal(Founder)Anna Kazlauskas(Founder)

Co-investorsAbstract VenturesAlphaLab CapitalCaladanEarl Grey CapitalParadigmSCB 10X+10 more

Vanavana.xyz𝕏Dec 2022 · $11.9M

Vana provides open data infrastructure for AI that lets individuals control the data they create and choose how it is used.

AI & Machine LearningCrypto & Web3Data & Infrastructure

Art Abal(Founder)

Co-investorsBoxGroupFlori VenturesCoinbase VenturesDeFiance CapitalExSight VenturesGSR+8 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.